Related Experiment Videos
Physical training increases osteoprotegerin in postmenopausal women
Ingrid Bergström1, Paolo Parini, Sven A Gustafsson
1Division of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. Ingrid.B.Bergstrom@karolinska.se
Journal of Bone and Mineral Metabolism
|August 9, 2011
Summary
Regular exercise in postmenopausal women increases osteoprotegerin (OPG) levels, helping to inhibit bone loss. This study found exercise benefits bone health by influencing the RANKL/OPG system, independent of sclerostin.
Area of Science:
- Endocrinology
- Exercise Physiology
- Bone Biology
Background:
- Postmenopausal bone loss is a significant health concern.
- The receptor activator for nuclear factor kappa B ligand/osteoprotegerin (RANKL/OPG) system and sclerostin are key regulators of bone metabolism.
- Understanding exercise's impact on these pathways is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the effect of a 1-year exercise program on the RANKL/OPG system and sclerostin levels in postmenopausal women.
- To determine if mechanical loading through exercise influences key molecular pathways involved in bone loss.
Main Methods:
- 112 postmenopausal women were randomized into a sedentary control group or a physical activity training group.
- The training program included brisk walking and aerobic sessions over 1 year.
- Serum levels of OPG, RANKL, sclerostin, CTX, and BALP were measured at baseline and after 1 year.
Main Results:
- The training group showed a significant increase in OPG levels compared to controls (p=0.007).
- Changes in RANKL and sclerostin levels were not statistically significant between groups.
- Bone turnover markers (CTX, BALP) tended to decrease in the training group, but changes were non-significant.
Conclusions:
- Exercise training in postmenopausal women is associated with increased OPG levels.
- This increase in OPG may contribute to the inhibition of postmenopausal bone loss.
- The exercise-induced effect on bone appears to be independent of RANKL and sclerostin modulation.
Related Concept Videos
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...